tetano
Editor, Senior Moderator
PLoS One. 2017 Jul 7;12(7):e0180143. doi: 10.1371/journal.pone.0180143. eCollection 2017.
[h=1]Boosting efferocytosis in alveolar space using BCG vaccine to protect host against influenza pneumonia.[/h] Mukherjee S[SUP]1[/SUP], Subramaniam R[SUP]1[/SUP], Chen H[SUP]1[/SUP], Smith A[SUP]1[/SUP], Keshava S[SUP]2[/SUP], Shams H[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Efferocytosis by alveolar phagocytes (APs) is pivotal in maintenance of lung homeostasis. Increased efferocytosis by APs results in protection against lethal acute lung injury due to pulmonary infections whereas defective efferocytosis by APs results in chronic lung inflammation. In this report, we show that pulmonary delivery of Bacillus Calmette-Guerin (BCG) significantly enhances efferocytosis by APs. Increased efferocytosis by APs maintains lung homeostasis and protects mice against lethal influenza pneumonia. Intranasally treated wild type C57Bl/6 (WT) mice with BCG showed significant increase in APs efferocytosis in vivo compared to their PBS-treated counterparts. All BCG-treated WT mice survived lethal influenza A virus (IAV) infection whereas all PBS-treated mice succumbed. BCG-induced resistance was abrogated by depleting AP prior to IAV infection. BCG treatment increased uptake, and digestion/removal of apoptotic cells by APs. BCG significantly increased the expression of TIM4 on APs and increased expression of Rab5 and Rab7. We demonstrated that increased efferocytosis by APs through pulmonary delivery of BCG initiated rapid clearance of apoptotic cells from the alveolar space, maintained lung homeostasis, reduced inflammation and protected host against lethal IAV pneumonia.
PMID: 28686604 DOI: 10.1371/journal.pone.0180143
[h=1]Boosting efferocytosis in alveolar space using BCG vaccine to protect host against influenza pneumonia.[/h] Mukherjee S[SUP]1[/SUP], Subramaniam R[SUP]1[/SUP], Chen H[SUP]1[/SUP], Smith A[SUP]1[/SUP], Keshava S[SUP]2[/SUP], Shams H[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Efferocytosis by alveolar phagocytes (APs) is pivotal in maintenance of lung homeostasis. Increased efferocytosis by APs results in protection against lethal acute lung injury due to pulmonary infections whereas defective efferocytosis by APs results in chronic lung inflammation. In this report, we show that pulmonary delivery of Bacillus Calmette-Guerin (BCG) significantly enhances efferocytosis by APs. Increased efferocytosis by APs maintains lung homeostasis and protects mice against lethal influenza pneumonia. Intranasally treated wild type C57Bl/6 (WT) mice with BCG showed significant increase in APs efferocytosis in vivo compared to their PBS-treated counterparts. All BCG-treated WT mice survived lethal influenza A virus (IAV) infection whereas all PBS-treated mice succumbed. BCG-induced resistance was abrogated by depleting AP prior to IAV infection. BCG treatment increased uptake, and digestion/removal of apoptotic cells by APs. BCG significantly increased the expression of TIM4 on APs and increased expression of Rab5 and Rab7. We demonstrated that increased efferocytosis by APs through pulmonary delivery of BCG initiated rapid clearance of apoptotic cells from the alveolar space, maintained lung homeostasis, reduced inflammation and protected host against lethal IAV pneumonia.
PMID: 28686604 DOI: 10.1371/journal.pone.0180143